VolitionRx Limited Schedules First Quarter 2025 Earnings Conference Call and Business Update

Rhea-AI Summary

VolitionRx Limited (NYSE AMERICAN: VNRX) has scheduled its First Quarter 2025 Earnings Conference Call and Business Update for Friday, May 16, 2025, at 8:30 a.m. U.S. Eastern Time. The call will be hosted by Louise Batchelor (Group Chief Marketing & Communications Officer), Cameron Reynolds (President and Group CEO), and Terig Hughes (Group CFO).

The conference call will discuss Q1 2025 financial and operating results, recent important events, and upcoming milestones. Participants can join via multiple channels including U.S. & Canada toll-free (1-877-407-9716), U.K. toll-free (0 800 756 3429), or international dial-in (1-201-493-6779). A live audio webcast will be available, and a replay will be accessible until May 30, 2025.

Conference call to take place on Friday, May 16 at 8:30 a.m. U.S Eastern Time

Henderson, Nev., May 12, 2025 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announces that it will host a conference call on Friday, May 16 at 8.30 a.m. U.S. Eastern Time to discuss its financial and operating results for the first quarter of 2025 and to provide a business update. Details of this event can be found below.

Event:   VolitionRx Limited First Quarter 2025 Earnings and Business Update Conference Call
Date:     Friday, May 16, 2025 
Time:    8:30 a.m. U.S. Eastern Time/2.30 p.m. Central European Time

U.S. & Canada Dial-in: 1-877-407-9716 (toll free)
U.K. Dial-in: 0 800 756 3429 (toll free)
Toll/International: 1-201-493-6779
Conference ID: 13753885

Louise Batchelor, Group Chief Marketing & Communications Officer will host the call along with Cameron Reynolds, President and Group Chief Executive Officer of Volition and Terig Hughes, Group Chief Financial Officer. The call will provide an update on important events that have taken place in the first quarter of 2025 and upcoming milestones.

A live audio webcast of the conference call will also be available on this link. In addition, a telephone replay of the call will be available until May 30, 2025. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the U.S. and Canada and 1-412-317-6671 (toll) internationally. Please use replay pin number13753885.

About Volition

Volition is a multi-national company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, disease and treatment monitoring.

Through its subsidiaries, Volition is developing and commercializing simple, easy to use, cost-effective blood tests to help detect and monitor a range of diseases, including some cancers and diseases associated with NETosis, such as sepsis. Early detection and monitoring have the potential to not only prolong the life of patients, but also to improve their quality of life.

Volition's research and development activities are centered in Belgium, with an innovation laboratory and office in the U.S. and London.

The contents found at Volition's website address are not incorporated by reference into this document and should not be considered part of this document.  Such website address is included in this document as an inactive textual reference only.

Media Enquiries:

Louise Batchelor, Volition, mediarelations@volition.com +44 (0)7557 774620

Investor Relations

Jeremy Feffer, LifeSci Advisors, jfeffer@lifesciadvisors.com +1-212-915-2568

View original content:https://www.prnewswire.com/news-releases/volitionrx-limited-schedules-first-quarter-2025-earnings-conference-call-and-business-update-302452316.html

SOURCE VolitionRx Limited

FAQ

When is VolitionRx (VNRX) reporting Q1 2025 earnings?

VolitionRx (VNRX) will report its Q1 2025 earnings on Friday, May 16, 2025, at 8:30 a.m. U.S. Eastern Time.

How can I listen to VNRX's Q1 2025 earnings call?

You can join via U.S. & Canada toll-free (1-877-407-9716), U.K. toll-free (0 800 756 3429), international dial-in (1-201-493-6779), or through a live audio webcast. Conference ID is 13753885.

Who will host VolitionRx's Q1 2025 earnings call?

The call will be hosted by Louise Batchelor (Group Chief Marketing & Communications Officer), Cameron Reynolds (President and CEO), and Terig Hughes (CFO).

Until when will VNRX's Q1 2025 earnings call replay be available?

The replay will be available until May 30, 2025, accessible via 1-844-512-2921 (U.S./Canada toll-free) or 1-412-317-6671 (international) using pin 13753885.